These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 23788293

  • 1. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ.
    Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
    [No Abstract] [Full Text] [Related]

  • 2. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G, Braunschweig F, Deharo JC, Leyva F, Lubinski A, Lazzaro C.
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [Abstract] [Full Text] [Related]

  • 3. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G, Suleiman M, Konstantino Y, Luria D, Kazatsker M, Chetboun I, Haim M, Gavrielov-Yusim N, Goldenberg I, Glikson M, Israeli Working Group on Pacing and Electrophysiology.
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [Abstract] [Full Text] [Related]

  • 4. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S, Duehmke R, Providencia R, Marijon E, Boveda S, Virdee M, Heck P, Fynn S, Begley D, Grace A, Agarwal S.
    Europace; 2018 Jan 01; 20(1):89-96. PubMed ID: 28031276
    [Abstract] [Full Text] [Related]

  • 5. Developing a crush: acute implantable cardioverter-defibrillator lead insulation break in a patient with multiple leads.
    Tilling L, Mason M.
    Europace; 2014 Aug 01; 16(8):1196. PubMed ID: 25074973
    [No Abstract] [Full Text] [Related]

  • 6. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
    Boriani G, Merino J, Wright DJ, Gadler F, Schaer B, Landolina M.
    Europace; 2018 Dec 01; 20(12):1882-1897. PubMed ID: 29757390
    [Abstract] [Full Text] [Related]

  • 7. The evolution and revolution of the implantable cardioverter defibrillator.
    Indik JH.
    Expert Rev Cardiovasc Ther; 2004 Jul 01; 2(4):461-4. PubMed ID: 15225105
    [No Abstract] [Full Text] [Related]

  • 8. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
    Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV.
    Circ Arrhythm Electrophysiol; 2014 Feb 01; 7(1):164-70. PubMed ID: 24446023
    [Abstract] [Full Text] [Related]

  • 9. Sex Differences in Inappropriate ICD Device Therapies: MADIT-II and MADIT-CRT.
    Tompkins CM, McNitt S, Polonsky B, Daubert JP, Wang PJ, Moss AJ, Zareba W, Kutyifa V.
    J Cardiovasc Electrophysiol; 2017 Jan 01; 28(1):94-102. PubMed ID: 27696593
    [Abstract] [Full Text] [Related]

  • 10. Increase of ventricular interval during atrial fibrillation by atrioventricular node vagal stimulation: chronic clinical atrioventricular-nodal stimulation download study.
    Bianchi S, Rossi P, Schauerte P, Elvan A, Blomström-Lundqvist C, Kornet L, Gal P, Mörtsell D, Wouters G, Gemein C.
    Circ Arrhythm Electrophysiol; 2015 Jun 01; 8(3):562-8. PubMed ID: 25878323
    [Abstract] [Full Text] [Related]

  • 11. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA.
    Nat Clin Pract Cardiovasc Med; 2008 Dec 01; 5(12):758-9. PubMed ID: 18838965
    [Abstract] [Full Text] [Related]

  • 12. Predictors for early mortality and arrhythmic events in patients with cardiac resynchronization therapy with defibrillator: A two center cohort study.
    Gunten SV, Theuns DA, Kühne M, Reichlin T, Sticherling C, Schaer B.
    Cardiol J; 2019 Dec 01; 26(6):711-716. PubMed ID: 30484267
    [Abstract] [Full Text] [Related]

  • 13. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
    Kusztal M, Nowak K.
    J Vasc Access; 2018 Nov 01; 19(6):521-527. PubMed ID: 29552930
    [Abstract] [Full Text] [Related]

  • 14. Management of functional Sprint Fidelis leads at cardiac resynchronization therapy-defibrillator generator replacement: a novel option for preventing inappropriate shocks from lead failure in fragile patients with high risk of sudden death.
    Zhu DWX, Chu MM, House CM.
    Europace; 2017 Dec 01; 19(12):2007-2014. PubMed ID: 27940933
    [Abstract] [Full Text] [Related]

  • 15. The implantable cardioverter-defibrillator: An update.
    Miller JD, Yousuf O, Berger RD.
    Trends Cardiovasc Med; 2015 Oct 01; 25(7):606-11. PubMed ID: 25912255
    [Abstract] [Full Text] [Related]

  • 16. The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?
    Botto GL, Forleo GB, Capucci A, Solimene F, Vado A, Bertero G, Palmisano P, Pisanò E, Rapacciuolo A, Infusino T, Vicentini A, Viscusi M, Ferrari P, Talarico A, Russo G, Boriani G, Padeletti L, Lovecchio M, Valsecchi S, D'Onofrio A, ‘AIAC S-ICD Why Not’ Survey Investigators.
    Europace; 2017 Nov 01; 19(11):1826-1832. PubMed ID: 28011803
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB, Solimene F, Pisanò EC, Zanotto G, Calvi V, Pignalberi C, Maglia G, Iacopino S, Quartieri F, Biffi M, Caravati F, Curnis A, Capucci A, Senatore G, Santamaria M, Della Bella P, Manzo M, Giacopelli D, Gargaro A, D'Onofrio A.
    J Cardiovasc Electrophysiol; 2019 Sep 01; 30(9):1626-1635. PubMed ID: 31165517
    [Abstract] [Full Text] [Related]

  • 18. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ, Rosengarten JA, Gnanapragasam JP, Haw MP, Morgan JM.
    Europace; 2013 Apr 01; 15(4):523-30. PubMed ID: 23333943
    [Abstract] [Full Text] [Related]

  • 19. Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure.
    Nichols CI, Vose JG, Mittal S.
    J Am Heart Assoc; 2016 Feb 12; 5(2):. PubMed ID: 26873688
    [Abstract] [Full Text] [Related]

  • 20. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM.
    Med Clin North Am; 2015 Jul 12; 99(4):795-804. PubMed ID: 26042883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.